« More new CPT codes a... | Main | How the E/M code RVU... »
Wednesday Jan 06, 2021
COVID-19 vaccines coding guide
The CPT Editorial Panel has approved unique codes for multiple COVID-19 vaccines, as well as administration codes for each dose of those vaccines. This list will be updated as more codes are approved.
| Manufacturer | Vaccine code | Description | Administration codes |
|---|---|---|---|
| Manufacturer: Pfizer | Vaccine code: 91300 | Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use | Administration codes: • 0001A (1st dose) • 0002A (2nd dose) |
| Manufacturer: Moderna | Vaccine code: 91301 | Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use | Administration codes: • 0011A (1st dose) • 0012A (2nd dose) |
| Manufacturer: AstraZeneca/Oxford | Vaccine code: 91302 | Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular use | Administration codes: • 0021A (1st dose) • 0022A (2nd dose) |
| Manufacturer: Janssen | Vaccine code: 91303 | Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular use | Administration codes: • 0031A (single-dose vaccine) |
The AMA has published a special edition CPT Assistant guide(www.ama-assn.org), which includes an appendix(www.ama-assn.org) to help identify each vaccine’s product code and administration code.
The AAFP is monitoring every aspect of the COVID-19 vaccine development process, including the Food and Drug Administration's Emergency Use Authorization reviews. Visit aafp.org/covidvaccine for updates to help prepare your practice and patients for the vaccines.
Posted at 11:45PM Jan 06, 2021 by FPM Editors
« More new CPT codes a... | Main | How the E/M code RVU... »
